Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00702247
What this trial is testing

Tandem Autologous- Nonmyeloablative Allogeneic Transplant for Newly Diagnosed Multiple Myeloma (Trapianto Tandem Autologo-Allogenico Non Mieloablativo Nel Mieloma Alla Diagnosi)

Who this might be right for
Multiple Myeloma
Azienda Ospedaliera San Giovanni Battista
Testing effectiveness (Phase 2)Active Not RecruitingNCT03114865
What this trial is testing

Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance

Who this might be right for
Acute Lymphoblastic LeukemiaB-cell Non Hodgkin LymphomaPre B-Cell Acute Lymphoblastic Leukaemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 44
Testing effectiveness (Phase 2)Study completedNCT00636909
What this trial is testing

Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders

Who this might be right for
AMLALLCML Chronic Phase, Accelerated Phase, or Blast Crisis+6 more
Beth Israel Deaconess Medical Center 25
Testing effectiveness (Phase 2)UnknownNCT03339700
What this trial is testing

Addition of Gemcitabine to Pre Allo-HSCT Conditioning for Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia, Adult
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 15
Testing effectiveness (Phase 2)Looking for participantsNCT06783790
What this trial is testing

Avapritinib Combined With Azacitidine and Venetoclax in the Treatment of Relapsed AML After Allo-HSCT

Who this might be right for
AML (Acute Myelogenous Leukemia)
Institute of Hematology & Blood Diseases Hospital, China 20
Not applicableUnknownNCT06241274
What this trial is testing

Moxibustion in the Treatment of Hemorrhagic Cystitis After Allo-HSCT

Who this might be right for
MoxibustionHematopoietic Stem Cell TransplantationHemorrhagic Cystitis+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 60
Not applicableStudy completedNCT04506320
What this trial is testing

Novel Drugs After Allo-HSCT in Patients With Multiple Myeloma

Who this might be right for
Multiple MyelomaStem Cell Transplant
Gruppo Italiano Trapianto di Midollo Osseo 202
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06075238
What this trial is testing

Blinatumomab Prevents Recurrence of R/R ALL After Allo-HSCT

Who this might be right for
Leukemia, Lymphoid
Sichuan University 68
Large-scale testing (Phase 3)Not Yet RecruitingNCT07588945
What this trial is testing

DaGOAT-Guided Prevention of Severe aGVHD After Allo-HSCT

Who this might be right for
Transplant-Related Disorder
Institute of Hematology & Blood Diseases Hospital, China 438
Not applicableUnknownNCT04051372
What this trial is testing

Diagnosis of Lung Complication After Allo-HSCT by Multiple Parameter System Through BAL

Who this might be right for
Bronchoalveolar Lavage FluidLung Infection
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 250
Large-scale testing (Phase 3)UnknownNCT05449899
What this trial is testing

G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for Secondary Acute Myeloid Leukemia Undergoing Allo-HSCT

Who this might be right for
Secondary Acute Myeloid Leukemia Evolving From MDSAllogeneic Hematopoietic Stem Cell TransplantationConditioning
Nanfang Hospital, Southern Medical University 232
Not applicableStudy completedNCT03606005
What this trial is testing

Physical Deteriorations in Allo-HSCT.

Who this might be right for
Stem Cell Transplantation
Gazi University 144
Not applicableStudy completedNCT07747246
What this trial is testing

Retrospective Study of Romiplostim for Platelet Engraftment After Allo-HSCT

Who this might be right for
Thrombocytopenia
Tongji Hospital 103
Testing effectiveness (Phase 2)UnknownNCT05583175
What this trial is testing

Venetoclax Plus RIC Regimen Allo-HSCT for Elderly Patients With High-risk Myeloid Malignancies

Who this might be right for
Leukemia, Myeloid, AcuteMDSHematopoietic Stem Cell Transplantation+1 more
Xianmin Song, MD 50
Not applicableLooking for participantsNCT07500441
What this trial is testing

Digital PCR of CHIP and MR for MRD Monitoring After Allo-HSCT in AML

Who this might be right for
Acute Myeloid Leukemia (AML)
Peking University People's Hospital 100
Large-scale testing (Phase 3)UnknownNCT03624530
What this trial is testing

Effect of Prophylactic TKI Therapy Post-transplants on Ph+ ALL Undergoing Allo-HSCT With MRD Positive Pre-transplants

Who this might be right for
Philadelphia Chromosome Positive Acute Lymphocytic LeukemiaTyrosine Kinase InhibitorMinimal Residual Disease+1 more
Nanfang Hospital, Southern Medical University 82
Not applicableLooking for participantsNCT06211166
What this trial is testing

Assessment of Measurable Residual Disease in Allo-HSCT Using Digital Polymerase Chain Reaction

Who this might be right for
Acute LeukemiaMDSMDS/MPN+1 more
Peking University People's Hospital 300
Testing effectiveness (Phase 2)UnknownNCT05809167
What this trial is testing

Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Lymphoblastic Leukemia Undergoing Allo-HSCT

Who this might be right for
Allogeneic Hematopoietic Stem Cell TransplantationAcute Lymphoblastic Leukemia
The First Affiliated Hospital of Soochow University 55
Testing effectiveness (Phase 2)Study completedNCT01252017
What this trial is testing

Nilotinib for Cytomegalovirus Prophylaxis and Treatment After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Patients Who Have Received Allo-HSCT
National Taiwan University Hospital 36
Not applicableStudy completedNCT01904175
What this trial is testing

Registry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell Transplant

Who this might be right for
Hodgkin's DiseaseNon Hodgkin's LymphomaMyeloma+2 more
Duke University 48
Next Page